Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029). The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, as ... Read More
-
Viral Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenoviral Vectors, Aden-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Others), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), By Application (Gene Therapy, Vaccinology), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Viral Vector Manufacturing market size is poised to register 13.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Preclinical CRO Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... of the COVID-19 pandemic garnered preclinical studies for pharmaceutical products such as vaccines, drugs, and other medical products. Thus, several laboratories and companies were engaged in conducting clinical trials for effective vaccines and drugs for ... Read More
-
Clinical Trials Imaging Market Size, Trends, Analysis, and Outlook By Service and Software (Services, Software), By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, Echocardiography), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, CVS, Endocrinology, Immunological Disorder), By End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic and Government Research Institutes), by Country, Segment, and Companies, 2024-2032
... CVS, Endocrinology, Immunological Disorder), By End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic and Government Research Institutes), by Country, Segment, and Companies, 2024-2032 The global Clinical Trials Imaging market size is ... Read More
-
Healthcare Regulatory Affairs Outsourcing Market Size, Trends, Analysis, and Outlook By Service (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Application, Others), By End-User (Pharmaceutical and Biotechnology Companies, Medical Device Companies), by Country, Segment, and Companies, 2024-2032
... Companies), by Country, Segment, and Companies, 2024-2032 The global Healthcare Regulatory Affairs Outsourcing market size is poised to register 9.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Acne Vulgaris (AV) - Competitive Landscape
... in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for AV. Topical retinoids and topical antibiotics are usually the first-line therapy for mild-to-moderate acne. The R&D activity is moderate within the AV space, ... Read More
-
North America Healthcare Cold Chain Logistics Market Report by Product (Biopharmaceuticals, Vaccines, Clinical Trials), Segment (Transportation, Packaging, Instrumentation), and Country 2024-2032
... 2023. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. The increasing cellular therapies and biomarker testing, escalating need to reduce ... Read More
-
Artificial Intelligence in Healthcare Market Report by Offering (Hardware, Software, Services), Technology (Machine Learning, Context Aware Computing, Natural Language Processing, and Others), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), End-User (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Patients, and Others), and Region 2024-2032
... Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), End-User (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Patients, and Others), and Region 2024-2032 The global artificial intelligence in healthcare market size reached US$ 6.1 Billion in ... Read More
-
Pharmacovigilance Market Analysis And Forecast To 2033: By Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-house and Contract Outsourcing), Type of Reporting (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), End User (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others), And By Region
... Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), End User (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others), And By Region The global Pharmacovigilance Market was valued at 7.1 billion in 2023 and it is ... Read More
-
Resistant Hypertension (RH) - Competitive Landscape
... in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for RH. The marketed drugs space for RH is dominated by off-label antihypertensive therapies. The R&D activity is limited within the RH space, with ... Read More
-
Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2024
... growth prospects across the Hypoactive Sexual Desire Disorder (HSDD) market. A detailed picture of the Hypoactive Sexual Desire Disorder (HSDD) pipeline landscape is provided, which includes the disease overview and Hypoactive Sexual Desire Disorder (HSDD) ... Read More
-
Focal Segmental Glomerulosclerosis (FSGS) - Epidemiology Forecast - 2034
... US. According to the analysis conducted by DelveInsight’s, FSGS was diagnosed in approximately 60% males and 48% of females within the 7MM in 2022. This analysis indicates a higher prevalence of FSGS among males than ... Read More
-
2024 Global Clinical Trial Imaging Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
2024 Global Clinical Trials Management Systems (Ctms) Market Industry (2030 Outlook)
... (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market ... Read More
-
2024 Global Clinical Trial Support Service Market Industry (2030 Outlook)
... Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product ... Read More
-
Complicated Urinary Tract Infections - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034
... years, immunotherapy has undergone a new phase of development which is linked to the development of CAR-T cell therapy. It is anticipated that CAR-T cells will bring out the next big leap forward in leukemia ... Read More
-
Alpha Receptor Agonist - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2024
... and growth prospects across Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline ... Read More
-
Alpha-1 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Alpha-1 Protease Inhibitor Deficiency - Pipeline Insight, 2024
... the Alpha-1 Protease Inhibitor Deficiency market. A detailed picture of the Alpha-1 Protease Inhibitor Deficiency pipeline landscape is provided, which includes the disease overview and Alpha-1 Protease Inhibitor Deficiency treatment guidelines. The assessment part of ... Read More
-
Alpha-Amylase Inhibitor - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Androgen Agonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Angiotensin Modulators - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Angiotensin Receptor Agonist - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
Research Assistance
